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Evidence shows urine specimens from different women have different populations of
bacteria. The co-occurrence of hypertension and hyperlipidemia in those with diabetes
may alter the composition of urine and the microenviroment of the bladder in which
bacteria live. The aim of this study was to characterize the urinary microbiota in women
with type 2 diabetes mellitus only and those with diabetes plus hypertension and/or
hyperlipidemia, and to explore whether the composition of the urinary microbiota is
affected by fasting blood glucose, blood pressure, and blood lipids. We enrolled 28
individuals with diabetes only, 24 with diabetes plus hypertension, 7 with diabetes
plus hyperlipidemia, and 11 with diabetes plus both hypertension and hyperlipidemia.
Modified midstream urine collection technique was designed to obtain urine specimens.
Bacterial genomic DNA was isolated using magnetic beads and the urinary microbiota
was analyzed using the Illumina MiSeq Sequencing System based on the V3-V4
hypervariable regions of the 16S rRNA gene. Among the four cohorts, the diabetes
plus hypertension cohort had the highest relative abundance of Proteobacteria. In
contrast, the diabetes plus hyperlipidemia cohort had the lowest relative abundance of
Proteobacteria. In addition, Escherichia and Gardnerella were not found in the diabetes
plus hyperlipidemia cohort but they were found in all of the other cohorts. Cetobacterium
was only present in the diabetes plus hypertension cohort. The most abundant bacteria
in the diabetes only and diabetes plus hyperlipidemia cohorts was Lactobacillus, while
Prevotella was the most abundant bacteria in the diabetes plus hypertension and
diabetes plus hypertension and hyperlipidemia cohorts. Moreover, the relative abundance
of Lactobacillus was significantly lower in the diabetes plus hypertension cohort than
in the diabetes only and diabetes plus hyperlipidemia cohorts. Several bacteria were
correlated with the participants’ fasting blood glucose, blood pressure, and blood lipids.
In conclusion, hypertension and/or hyperlipidemia and other patient factors can affect
the composition of the urinary microbiota in those with diabetes. The insights from this
study could be used to develop microbiota-based treatment for comorbid conditions,
including urinary tract infections, in those with diabetes.
Keywords: type 2 diabetes mellitus, hypertension, hyperlipidemia, Lactobacillus, Proteobacteria, urinary
microbiota
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INTRODUCTION
The number of people around the world with diabetes has
risen from 108 million in 1980 to 422 million in 2014 (World
Health Organization, 2016). Type 2 diabetic mellitus (T2DM)
accounts for approximately 90–95% of cases of diabetes (Rubino,
2008). Up to 75% of the adult population with diabetes has
hypertension and approximately 52.8% of those with diabetes
have hyperlipidemia (de Sereday et al., 2004; Long and Dagogo-
Jack, 2011).
Recent evidence has shown that urinary microbiota profiles
are complex and they vary considerably between individuals,
both in women and men (Dong et al., 2011; Siddiqui et al.,
2011, 2012; Fouts et al., 2012; Wolfe et al., 2012; Lewis
et al., 2013; Fricke et al., 2014; Nienhouse et al., 2014; Pearce
et al., 2014, 2015; Santiago-Rodriguez et al., 2015; Shoskes
et al., 2016; Thomas-White et al., 2016a,b). The main urinary
bacteria in healthy women are Lactobacillus, Prevotella, and
Gardnerella (Siddiqui et al., 2011). Although patients with
urinary urgency incontinence have been shown to have higher
levels of Gardnerella and Lactobacillus gasseri than controls,
they have also been shown to have lower levels of Lactobacillus
crispatus (Pearce et al., 2014). Women undergoing surgery for
stress urinary incontinence have been shown to have increased
urinary bacterial diversity, and this diversity has been shown to
be affected by hormone status (there were differences between
premenopausal women, and postmenopausal women with or
without current exogenous hormone use), body mass index, and
the symptoms of stress urinary incontinence (Thomas-White
et al., 2016b). In addition, the urinary microbiota has been
demonstrated to be affected by age. For example, the urinary
microbiota of men and women who were 70 years old or over
were dominated by Jonquetella, Parvimonas, Proteiniphilum, and
Saccharofermentans (Lewis et al., 2013). Elderly healthy females
had significantly lower relative abundance of Lactobacillus than
non-elderly (Liu et al., 2016).
Studies have demonstrated that individuals with T2DM,
and those with comorbid conditions such as hypertension and
hyperlipidemia, have alterations in their intestinal microbiota
profiles. The risk of developing T2DM and hyperlipidemia
has been reported to be correlated with an alteration in the
composition and the function of the intestinal microbiota (Suez
et al., 2016). For instance, functional analysis demonstrated that
the microbiota of T2DM patients had decreased pathways of
bacterial chemotaxis, flagellar assembly, butyrate biosynthesis
and metabolism of cofactors and vitamins (Qin et al., 2012).
The occurrence of T2DMmay also be associated with changes
in urinary microbiota profiles, as having diabetes can change the
microenvironment of the urinary tract in which bacterium live.
For example, those with diabetes can have increased levels of
glucose in their urine as a result of their high levels of blood
glucose. These high levels of blood glucose can progressively
damage the glomeruli, reducing their ability to filtrate blood and
causing protein to leak out of the kidneys into the urine.
Hypertension may also be associated with changes in urinary
microbiota profiles as it is correlated with an increase in
the activity of the renin-angiotensin-aldosterone system, which
affects the amount of water excreted by the kidneys (Basi et al.,
2008). In addition, higher sodium and lower potassium in
the urine are more prevalent in those with hypertension than
in those without hypertension (Kieneker et al., 2014; Mente
et al., 2016). Furthermore, impaired kidney function is associated
with hyperlipidemia (Chen et al., 2016), which can cause high
levels of proteinuria (Gordillo and Spitzer, 2009). Thus, the co-
occurrence of hypertension and/or hyperlipidemia with T2DM
can affect the composition of urine, which can then affect the
microenvironment of the urinary tract and consequently alter
bacterial growth.
So far, no study has explored the relationship between the
urinary microbiota and comorbidities in those with T2DM.
We speculate that the composition changes in urine caused
by comorbid hypertension, hyperlipidemia and urinary tract
infections in female T2DM patients can alter the urinary
microbiota profile. Thus, the aim of this study was to investigate
the changes in the urinary microbiota profiles of women with
T2DM only and those with T2DM plus hypertension and/or
hyperlipidemia, and the correlation between the profiles and
patient characteristics, i.e., fasting blood glucose (FBG), blood
pressure (BP), blood lipids (BL), asymptomatic bacteriuria
(according to urine cultures) and nitrite-positive samples (which
are indicative of urinary tract infections).
MATERIALS AND METHODS
Recruitment of Subjects
Seventy individuals with T2DM were divided into four cohorts:
28 were allocated to the T2DM only (DM) cohort, 24 to the
T2DM plus hypertension (DM+HT) cohort, 7 to the T2DM plus
hyperlipidemia (DM+HLP) cohort, and 11 to the T2DM plus
both hypertension and hyperlipidemia (DM+HT+HLP) cohort.
The participants had been previously diagnosed (with T2DM
only or with T2DM plus hypertension and/or hyperlipidemia)
by clinicians in local provincial or municipal hospitals in China.
They were enrolled at the Endocrinology Department of the
First Affiliated Hospital, School of Medicine, Zhejiang University
from June 2015 to January 2016. Written informed consent
was obtained from the participants prior to enrollment, and
approval for the study was obtained from the Ethics Committee
of the First Affiliated Hospital (reference number: 295). The
following exclusion criteria were applied: a urinary tract infection
(UTI) in the previous month, antibiotic use in the previous 3
months, inability to complete the questionnaire, menstruation,
urinary incontinence, known anatomical abnormalities of the
urinary tract (e.g., cystoceles, hydronephrosis, renal atrophy,
or neurogenic bladder), and use of a urinary catheter. Each
participant’s most recent FBG, BP, and BL values were obtained
from their medical records. Water intake was assessed using the
Chinese Food Frequency Questionnaire (Zhao et al., 2010).
Collection and Processing of Urinary
Samples
The samples collected contained the first urine of the day. The
participants were taught to use a modified midstream urine
(MMSU) collection technique that involved disinfection and a
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four-tube collection method. The MMSU collection technique
involved the following steps: (a) A polyvinylpyrrolidone-iodine
antiseptic (Dian’erkang, Shanghai, China) was poured onto
sterile cotton balls, which were then placed into a 40 mL sterile
sputum cup. (b) Four 50-mL sterile centrifuge tubes (which were
labeled tube 1, 2, 3, and 4) were opened and the lids were placed
upwards so that the participant would not touch the interior
or top edge of either the tubes or the lids. (c) The participant
pulled her underwear down to her knees and squatted on a squat
toilet, with legs spread apart. (d) The participant disinfected the
thumb, middle finger, and index finger of each hand twice with
the polyvinylpyrrolidone-iodine antiseptic. (e) The participant
used her dominant hand to pick up one of the cotton balls
covered with antiseptic, cleaned the far labial fold, starting from
above the urinary meatus down toward the rectum. The cotton
ball was then discarded without crossing the sterile field that
had previously been disinfected. The near labial fold was then
disinfected by cleaning down the center of the urinary meatus.
The labia were held apart to prevent the labia minora from
falling back over the urinary meatus. (f) After disinfection, the
participant urinated into tube 1 until half the tube was filled.
Then, without stopping the flow of urine, the participant urinated
into tubes 2, 3, and 4 in that order. The redundant urine was
voided to the toilet. All the tubes were filled up to the halfway
mark except for tube 2, which was filled up to the labeled
line (representing 40mL of urine). After training, we asked the
participant demonstrating the MMSU technique to assess their
competency to perform the procedure. The collection procedure
was supervised by a senior nurse.
Each sample was given an anonymous identification code. The
urine in tubes 2 and 3 was separated into three aliquots: 15 mL
for urinalysis, 1 mL for urine culture, and 40mL for bacterial
DNA sequencing. The urine in tubes 1 and 4 was discarded,
which could guarantee that genuine mid-stream urine was used
in the experiment. The urinalysis involved testing the sample for
nitrites. The urine cultures were performed by inoculating blood
agar plates and incubating them at 37◦C for 48 h. Asymptomatic
bacteriuria was defined as the presence of ≥105 CFU/mL of
the same bacterial strain in two consecutive MMSU specimens
(Varli et al., 2012). If asymptomatic bacteriuria was diagnosed,
urine from the second MMSU specimen was used for bacterial
DNA sequencing. A self-report questionnaire was used to collect
demographic characteristics.
DNA Extraction, PCR, and MiSeq
Sequencing
Forty mL urine was aspirated from tubes 2 and 3, separated into
three sections and injected into three 15 mL sterile centrifuge
tubes. Each of them was pelleted by centrifugation at 4,000
× g for 15min at 4◦C. Ten milliliter of the supernatant was
decanted and the pellet was obtained by centrifugation for
15min at 4,000 × g at 4◦C. The pellet was injected into a
2 mL sterile centrifugation tube which contained 500µL of
lysis buffer, which was composed of 1 M Tris-HCl (pH 8.03),
NaCl, 0.5 M EDTA (pH 7.97), and SDS. The tube was kept at
−80◦C until DNA extraction. The method of magnetic beads
isolation of genomic DNA from bacteria was based on the
manufacturer’s protocol withminor modifications (Shoskes et al.,
2016). The tube was placed in liquid nitrogen for 1min, and
transferred into a water bath at 65◦C for 5min, with vigorous
mixing. This last process was repeated three times with a final
maintenance in the water bath for 30min. 50µL Agencourt
AMPure XP (Beckman Coulter, USA) was added to 100µL of
the urine pellet, vortexed for 30 s and incubated for 5min at
room temperature. The tube was placed into amagnetic separator
for 5min, and DNA was bound to magnetic beads which were
drawn to the wall of the microcentrifuge tube. The supernatant
was carefully removed without disrupting the magnetic beads.
The sample was washed twice with 200µL 80% ethanol for
30 s, being placed on a magnet separator between each washing.
The purified DNA was eluted with 50µL ddH2O for 1min.
The beads, now released from the DNA, were collected with
the magnet, The DNA-containing supernatant was transferred
to a clean tube. The concentration of extracted DNA was
determined by using a NanoDrop ND-1000 spectrophotometer
(Thermo Electron Corporation, USA); its integrity and size
were checked by 1.0% agarose gel electrophoresis containing 0.5
mg/mL ethidium bromide. The DNA complex was placed at
−20◦C until PCR amplification. We failed to extract sufficient
DNA for sequencing from the sample of one participant, so
this participant was replaced by another who had similar
demographic characteristics.
The 16S rRNA gene V3-V4 regions were PCR-amplified
from microbial genome DNA using primers (forward primer,
5′-ACTCCTACGGGAGGCAGCAG-3′; reverse primer, 5′-GGA
CTACHVGGGTWTCTAAT-3′; Fadrosh et al., 2014). All crucial
steps during sample processing, DNA isolation and the entire
PCR set up were performed in a laminar air flow bench,
illuminated with a UV lamp prior to use in order to avoid possible
contaminants. In addition, negative DNA extraction controls
(lysis buffer and kit reagents only) were amplified and sequenced
as contamination controls. The amplicons were normalized,
pooled and sequenced on the Illumina MiSeq instrument using
a 300× 2 V3 kit.
Bioinformatics Analysis and Statistical
Analysis
Sequence reads processing was performed using QIIME (version
1.9.0) (Caporaso et al., 2010) and included additional quality
trimming, demultiplexing, and taxonomic assignments. Profiling
of predictive urinary microbiota was analyzed by using PICRUSt
based on the Greengenes database as of 13 August 2013
(DeSantis et al., 2006) (BioProject number: 329477; Accessing
number: SRP087709). Specifically, the processed sequences
were subjected to subsampled open-reference operational
taxonomic unit (OTU) picking against Greengenes, clustering
unmatched reads with 97% identity into OTUs. QIIME
was used to calculate the Shannon-Weiner indices, and
phylogenetic (alpha) diversity. The diversity and richness
of the bacteria in the urine samples were calculated using
several estimates. These consisted of the level of OTUs,
which provides a measure of bacterial richness), Chao1
Frontiers in Physiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 126
Liu et al. Illnesses Associated with T2DM Microbiota
(which is also an estimate of bacteria richness) and the
Shannon and Simpson indices (which are measures of bacterial
diversity).
Statistical analysis was performed using the SPSS data analysis
program (version 21.0). For continuous variables, Independent
t-tests and Mann-Whitney U-test was applied. For categorical
variables between groups, using either the Pearson chi-square or
Fisher’s exact test, depending on assumption validity. For taxon
between cohorts, Mann-Whitney U-test was applied. All tests
of significance were two sided, and p < 0.05 was considered
statistically significant. FDR was used as a correction approach to
control the false discovery rate (Shoskes et al., 2016). The receiver
operating characteristic curve was plotted and the area under
curve of each predictive model was calculated using SPSS.
RESULTS
Cohort Description
Table 1 displays the baseline characteristics of the participants
in each cohort. The mean age in the DM+HT cohort was
significantly greater than those in the DM and DM+HLP
cohorts, the mean age in the DM+HT+HLP cohort was
significantly greater than those in the DM and DM+HLP
cohorts. The duration of T2DM was significantly shorter in the
DM and DM+HLP cohorts than in the DM+HT cohort. Those
in the DM+HT cohort were also less likely to be premenstrual
compared to those in the DM cohort.
Sequencing Data
We obtained 5,175,509 raw sequences from the 70 samples,
with a median read length of 2 × 300 and 443 base pairs.
After filtering and removing the chimeric sequences, we obtained
3,981,519 reads for further analysis, which accounted for 76.93%
of the valid reads, with a mean of 56,878.84 reads (ranging from
13,419 to 146,528) per sample. The mean read length was 438
bp (ranging from 423 to 436). The value of Good’s coverage
estimator was 98%.
As shown in Table 2, the numbers of reads and OTUs were
significantly higher in the DM+HT cohort compared to in the
DM and DM+HLP cohorts. In addition, the number of OTUs
was dramatically higher in the DM+HT+HLP cohort compared
to in the DM+HLP cohort.
Comorbid Conditions with T2DM were
Associated with Alterations in the Urinary
Microbiota Profiles
The numbers of bacterial phyla detected in the DM, DM+HT,
DM+HLP, and DM+HT+HLP cohorts were 40, 37, 30,
and 26, respectively. The predominant bacterial phyla in
the DM cohort were Proteobacteria (58.27%), Firmicutes
(20.83%), Bacteroidetes (10.14%), Actinobacteria (7.52%), and
Fusobacteria (1.06%). The DM+HT cohort was dominated by
Proteobacteria (60.18%), Firmicutes (20.60%), Bacteroidetes
(11.20%), Actinobacteria (5.36%), and Synergistetes (0.54%). The
DM+HLP cohort was dominated by Proteobacteria (50.26%),
Firmicutes (24.43%), Bacteroidetes (13.36%), Actinobacteria
(9.21%), and Acidobacteria (1.18%). The DM+HT+HLP
cohort was dominated by Proteobacteria (37.29%), Firmicutes
(22.78%), Bacteroidetes (22.47%), Actinobacteria (15.33%), and
Fusobacteria (0.82%).
The numbers of bacterial genera in the DM, DM+HT,
DM+HLP, and DM+HT+HLP cohorts were 320, 303, 236, and
225, respectively. The genera detected in each of the cohorts
are shown in Table S1. Of the genera in the DM cohort, 61,
103, and 108 were not detected in the DM+HT, DM+HLP,
and DM+HT+HLP cohorts, respectively. Of the genera in the
DM+HT cohort, 41, 86, and 102 were not found in the DM,
DM+HLP, and DM+HT+HLP cohorts, respectively. Of the
genera in the DM+HLP cohort, 26, 6, and 60 were absent from
the DM, DM+HT, and DM+HT+HLP cohorts, respectively.
Finally, of the genera in the DM+HT+HLP cohort, 23, 26, and
53 were not present in the DM, DM+HT, and DM+HT+HLP
cohorts.
The predominant genera in the DM cohort were Lactobacillus,
Prevotella, and Acinetobacter (Figure 1A). The DM+HT
cohort was dominated by Prevotella, Streptococcus, and
Bacteroides, and Lactobacillus only accounted for 5% of the DNA
sequences (Figure 1B). The samples from the DM+HLP cohort
primarily consisted of Lactobacillus, Prevotella, and Halomonas
(Figure 1C). The most common genera in the DM+HT+HLP
cohort were Prevotella, Lactobacillus, and Bacillus (Figure 1D).
The levels of Aeromonas, Roseburia, and Ruminococcus
were significantly lower in the DM cohort compared to
in the DM+HT cohort, while Lactobacillus, Enterobacter,
Klebsiella, etc. were dramatically higher in the DM cohort
compared to in the DM+HT cohort (Figure 2A). Compared
to the DM cohort, the relative abundances of Faecalibacterium,
Oscillospira, and Collinsella were significantly higher in the
DM+HLP cohort (Figure 2B). In addition, compared to in
the DM cohort, the relative abundance of Prevotella was
significantly higher in the DM+HT+HLP cohort, while those
of Shuttleworthia, Acinetobacter, and Gemella were dramatically
lower in the DM+HT+HLP cohort (Figure 2C). The levels
of Klebsiella, Novosphingobium, Lactobacillus, and Enterobacter
were significantly lower in the DM+HT cohort compared to
in the DM+HLP cohort (Figure 2D). The relative abundance
of Faecalibacterium was significantly higher in the DM+HLP
cohort compared to in the DM+HT+HLP cohort (0.02 ± 0.02
vs. 0.01 ± 0.01, p = 0.040). In addition, as shown in Figure 3,
the receiver operating characteristic curve analysis demonstrated
that Oscillospira was capable of being used as a diagnostic factor
for distinguishing those in the DM+HLP cohort from those in
the DM cohort.
To better understand the relationships between urinary
microbiota and individual characteristics such as FBG, BP, and
BL, correlation analyses were carried out. The bacteria that
were significantly correlated with the three factors are listed in
Tables S2–S5. In the DM cohort, the levels of 4 genera were
positively correlated with FBG (Table S2). In theDM+HT cohort,
the relative abundance of 8 and 14 genera was positively and
negatively correlated with systolic BP, respectively. In addition,
15 genera were negatively correlated with diastolic BP in the
DM+HT cohort (Table S3). In the DM+HLP cohort, the levels
of 15 and 29 genera were positively correlated with triglycerides
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TABLE 1 | Characteristics of the DM, DM+HT, DM+HLP, and DM+HT+HLP cohortsa.
Characteristicb DM (n = 25) DM+HT (n = 24) DM+HLP (n = 7) DM+HT+HLP (n = 11)
Age 56.28 ± 13.91*,U 70.42 ± 9.00*,$ 54.43 ± 10.66$,θ 69.81 ± 9.64U,θ
Body mass index (kg/m2) 23.74 ± 23.41 23.41 ± 4.13 23.63 ± 3.91 25.31 ± 3.48
MENSTRUAL STATUS (%)
Premenopausal 28.00* 0.00* 14.29 9.09
Postmenopausal 64.00 100.00 71.43 90.91
Hysterectomy 8.00 0.00 14.29 0.00
MARITAL STATUS (%)
Living with partner 96.00 79.17 100.00 90.91
Divorced 4.00 8.33 0.00 0.00
Widowed 0.00 12.50 0.00 9.09
TOBACCO USE (%)
Never 96.00 100.00 100.00 0.00
Occasionally 4.00 0.00 0.00 0.00
Frequently 0.00 0.00 0.00 0.00
ALCOHOL USE (%)
Never 68.00 87.50 0.00 90.91
Occasionally 28.00 8.33 0.00 9.09
Frequently 4.00 4.17 0.00 0.00
Fasting blood glucose (mmol/L) 7.79 ± 2.04 7.63 ± 1.74 8.26 ± 5.24 8.40 ± 1.94
Duration of diabetes (years) 6.92 ± 5.60* 14.42 ± 8.75*,$ 5.71 ± 4.79$ 9.09 ± 6.07
Urinary tract infections over the previous yearc 0.52 ± 0.71 0.63 ± 1.24 0.70 ± 0.49 1.00 ± 1.90
Asymptomatic bacteriuria (%) 1.43 4.29 0.00 2.86
Positive for nitrites (%)c 0.00 5.71 0.00 2.86
Systolic/diastolic blood pressure (mmHg) N/A 142.29 ± 11.59/85.67 ± 7.61 N/A 144.55 ± 8.77/85.82 ± 12.05
Triglycerides (mmol/L) N/A N/A 3.37 ± 1.80 2.15 ± 0.43
Low-density lipoprotein cholesterol (mmol/L) N/A N/A 3.08 ± 2.38 3.34 ± 0.54
High-density lipoprotein cholesterol (mmol/L) N/A N/A 2.50 ± 1.43 2.04 ± 0.60
Total cholesterol (mmol/L) N/A N/A 5.05 ± 1.05 5.56 ± 0.81
aDM, diabetes mellitus; HLP, hyperlipidemia; HT, hypertension; N/A, not applicable.
b Independent t-test and Pearson’s chi-square test were used to test for significant differences (p < 0.05) in each variable between the four cohorts.
cThe population with “urinary tract infections over the previous year” and “positive for nitrites” came from general population who have not been diagnosed with urinary tract infection
in the last month and had not been previously diagnosed with urinary incontinence.
*Represents a significant difference between the DM and DM+HT cohorts; URepresents a significant difference between the DM and DM+HT+HLP cohorts; $Represents significant
difference between the DM+HT and DM+HLP cohorts; and θRepresents a significant difference between the DM+HLP and DM+HT+HLP cohorts.
TABLE 2 | Richness and diversity estimators in the DM, DM+HT, DM+HLP, and DM+HT+HLP cohortsa.
Parameterb DM DM+HT DM+HLP DM+HT+HLP
Number of reads 48522.68 ± 23491.16* 67119.25 ± 37614.50*,U 36055.57 ± 23166.08U 64456.27 ± 33866.88
Number of OTUsa,b 40247.36 ± 18946.19* 57655.67 ± 32647.91*,U 28891.14 ± 17367.94U,$ 55127.36 ± 28204.73$
ACEa 4421.07 ± 2466.79 3382.38 ± 2102.71 3874.37 ± 2606.88 3577.61 ± 2128.65
Chao1 4122.27 ± 2315.01 3099.59 ± 1875.36 3528.80 ± 2304.51 3188.44 ± 1842.75
Shannon index 3.99 ± 2.21 3.95 ± 2.61 5.21 ± 2.22 4.41 ± 1.79
Simpson index 0.65 ± 0.22 0.61 ± 0.28 0.76 ± 0.24 0.75 ± 0.23
aACE, abundance-based coverage estimators; DM, diabetes mellitus; HLP, hyperlipidemia; HT, hypertension; OTU, operational taxonomic units.
bThe operational taxonomic units (OTUs) were defined based on a similarity threshold of 97%; Independent t-test was used to test for significant differences (p < 0.05) in each variable
between the four cohorts. *, U , and $ indicate significant differences between the DM and DM+HT cohorts, between the DM+HT and DM+HLP cohorts, and between the DM+HLP
and DM+HT+HLP cohorts, respectively. The parameters were calculated using QIIME software.
The parameters were calculated using QIIME software.
and high-density lipoprotein cholesterol (HDL-C), respectively.
In the DM+HLP cohort, 8 and 10 genera were negatively
correlated with low-density lipoprotein cholesterol (LDL-C) and
total cholesterol, respectively (Table S4). In the DM+HT+HLP
cohort, the levels of 11 and 1 genera were positively and
negatively correlated with systolic and diastolic BP, respectively.
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FIGURE 1 | Summary of bacterial genera detected in the four cohorts. (A–D) indicate the top 10 most abundant genera detected in the DM, DM+HT,
DM+HLP, and DM+HT+HLP cohorts, respectively. DM, diabetes mellitus; HLP, hyperlipidemia; HT, hypertension.
Thirteen genera were negatively correlated with triglycerides,
37 were positively correlated with LDL-C, 2 were correlated
with HDL-C (one was positively correlated and the other was
negatively correlated), and 5 and 10 genera were positively and
negatively correlated with total cholesterol (Table S5). No genera
were correlated with FBG in any of the cohorts.
At the species level, those in the DM+HT cohort had
significantly lower relative abundances of Lactobacillus iners,
Acinetobacter rhizosphaerae, and Acinetobacter schindleri than
those in the DM cohort (2.14 ± 10.23 vs. 9.15 ± 22.36, p =
0.001; 0.03 ± 0.08 vs. 0.16 ± 0.19, p = 0.001; 0.00 ± 0.00 vs.
0.01 ± 0.03, p = 0.019, respectively). In contrast, they also had
a higher relative abundance of Kocuria palustris compared to
those in the DM cohort (0.01 ± 0.03 vs. 0.00 ± 0.0, p = 0.042).
Interestingly, Eggerthella lenta, which was not detected in the
DM cohort, was found in the DM+HT cohort. In addition,
Deinococcus aquatilis, which was detected in the DM cohort, was
absent in the DM+HT cohort. Additionally,A. rhizosphaeraewas
significantly lower in the DM+HT+HLP cohort compared to
in the DM cohort (0.01 ± 0.03 vs. 0.16 ± 0.19, p = 0.003). A.
rhizosphaerae was also significantly lower in the DM+HT+HLP
cohort compared to in the DM+HLP cohort (0.00± 0.00 vs. 0.06
± 0.07, p= 0.001).
To explore the association between nutrients intake
and the relative abundance of bacterial genus in urinary
microbiota and between nutrients intake and medicine
intake, we compared the difference of nutrients intake
among DM, DM+HT, DM+HLP, and DM+HT+HLP
group, and there were difference in energy, protein, fat,
carbohydrate, vitamin B1,vitamin B2, vitamin C, vitamin E,
potassium, sodium, magnesium, selenium, copper, manganese,
monounsaturated fatty acid, polyunsaturated fatty acid and
aspirin intake among groups. We have found that some
nutrients intake were weak or mild positively or negatively
associated with urinary microbiota (r < 0.7, p < 0.05;
Tables S6, S7).
DISCUSSION
Hypertension appears to increase urinary bacterial diversity,
as those in the DM+HT and DM+HT+HLP cohorts had
larger numbers of reads and/or OTUs compared to those in
the DM and DM+HLP cohorts. Hyperlipidemia may lower
the diversity of the microbiota, as the DM+HLP cohort
had lower numbers of reads and OTUs compared to the
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FIGURE 2 | Genus-level operational taxonomic units that were significantly different between the four cohorts. Mann-Whitney U-tests were used to
compare the differences in the relative abundance of bacterial genera between pairs of cohorts. (A–D) indicate the significant differences (p < 0.05) between the DM
and DM+HT cohorts, between the DM and DM+HLP cohorts, between the DM and DM+HT+HLP cohorts, and between the DM+HT and DM+HLP cohorts,
respectively. DM, diabetes mellitus; HLP, hyperlipidemia; HT, hypertension.
DM+HT cohort. The results were similar at both the phylum
and genus levels. Among the four cohorts, subjects with
hyperlipidemia had a lower presence of bacteria than those
without hyperlipidemia.
The top four most abundant bacteria in the four cohorts were
(in various orders) Proteobacteria, Firmicutes, Bacteroidetes,
and Actinobacteria. This is somewhat similar to the findings of
several previous studies on urinary microbiota profiles, as in
these previous studies, one of the most abundant bacteria was
Proteobacteria, which were generally ranked as the second or
third most abundant bacteria, though they sometimes ranked
lower (Siddiqui et al., 2011, 2012; Pearce et al., 2014; Karstens
et al., 2016; Thomas-White et al., 2016a).
Among the four cohorts, the rates of participants with
asymptomatic bacteriuria and nitrite-positive samples were the
highest in the DM+HT cohort. Interestingly, among the four
cohorts, the relative abundance of Proteobacteria was also the
highest in the DM+HT cohort. Lewis et al. (2013) reported
that Proteobacteria was the predominant phylum in nitrite-
positive samples in their study. The findings in our study and
the study by Lewis et al. indicate that the relative abundance of
Proteobacteria may be correlated with UTIs. Evidence has shown
that hypertension is a risk factor for UTIs in those with diabetes
(Al-Rubeaan et al., 2013). This suggests that Proteobacteria may
play a role in the high prevalence of UTIs in those with diabetes
and comorbid hypertension.
Interestingly, asymptomatic bacteriuria and nitrite-positive
samples were not found in the DM+HLP cohort and, among
the four cohorts, the DM+HLP cohort had the lowest relative
abundance of Proteobacteria. In addition, Escherichia which
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FIGURE 3 | Receiver operating characteristic curve analysis of
sensitivity and specificity of the taxon sequence. The analysis evaluated
the use of the relative abundance of Oscillospira as a diagnostic factor for
distinguishing between those with diabetes only from those with diabetes plus
hyperlipidemia. SPSS software was used for the ROC curve analysis. The
diabetes only was labeled with “0” and the diabetes plus hypertenstion was
labeled with “1,” and the value of state variable was set “1.”
is one of the most frequent uropathogens (Reygaert, 2014),
a genus belonging to Proteobacteria, was not detected in the
DM+HLP cohort (Table S1). This suggests that the absence
of asymptomatic bacteriuria and nitrite-positive samples in the
DM+HLP cohort may be due to the low relative abundance of
Proteobacteria and the absence of Escherichia in the urine. This
may indicate that there is a microbiota-related regulating system
that prevented those in the DM+HLP cohort from developing
UTIs. This is consistent with the finding that, although the
co-occurrence of hyperlipidemia and diabetes can increase the
body’s inflammatory response (Casqueiro et al., 2012; Chen
S. et al., 2014), there were no indications of UTIs (by either
asymptomatic bacteriuria or nitrite-positive samples) in the
DM+HLP cohort.
Several bacteria were not present in the DM+HLP cohort,
but were detected in the three other cohorts such as
Gardnerella, which has been reported to be a major urotype
in previous studies (Thomas-White et al., 2016a,b). Price
et al. found that Gardnerella was present more often in non-
UTI samples than in UTI samples (Price et al., 2016), but
in the present study, there were no participants with either
asymptomatic bacteriuria or nitrite-positive samples in the
DM+HLP cohort. Notably, Akkermansia and Bifidobacterium,
which are considered probiotic bacteria, were detected in
all four cohorts. In a previous intestinal microbiota study,
the relative abundance of Akkermansia was lower in patients
with inflammatory diseases compared to healthy humans, and
was also lower in diabetic mice (Dingemanse et al., 2015).
Bifidobacterium has been shown to be able to reduce levels of
intestinal endotoxins and improve the mucosal barrier, which
results in reduced systemic inflammation (Cani et al., 2008).
Although T2DM, hypertension, and hyperlipidemia can increase
an individual’s inflammatory response (Casqueiro et al., 2012;
Mangin, 2014; Chen S. et al., 2014), the subjects in the DM,
DM+HT, and DM+HLP cohorts did not have a higher incidence
of UTIs (in the previous year) compared to the incidence of
UTIs (0.5–0.7 per year) reported by Hooten et al. in healthy
women (Hooton et al., 1996). This may be due to the presence of
bacteria in urine (such as Akkermansia and Bifidobacterium) that
help to combat the inflammatory responses caused by diabetes,
hypertension, and hyperlipidemia in order to maintain healthy
urinary conditions.
Themost abundant bacteria in the DM andDM+HLP cohorts
was Lactobacillus, which is similar to the findings of previous
studies (Siddiqui et al., 2011, 2012; Pearce et al., 2014, 2015;
Thomas-White et al., 2016b). However, Lactobacilluswas the fifth
most abundant bacteria and only accounted for 5% of the DNA
sequences in the DM+HT cohort, and the level of Lactobacillus
was significantly lower in the DM+HT cohort compared to in
the DM cohort. The relative abundance of Lactobacillus may
have been affected by the participants’ ages, as the participants
in the DM+HT and DM+HT+HLP cohorts were significantly
older than those in the DM and DM+HLP cohorts. Thomas-
White et al. reported a similar finding in their study of urgency
incontinence patients, i.e., the urgency incontinence patients
were significantly older than the healthy controls, and they had
a significantly lower proportion of Lactobacillus in their urine
(Thomas-White et al., 2016a). Moreover, the DM+HT cohort
included fewer premenopausal women than the DM cohort.
A recent study demonstrated that premenopausal women and
postmenopausal women taking exogenous hormones had higher
levels of Lactobacillus in their urine compared to postmenopausal
women who were not taking exogenous hormones (Thomas-
White et al., 2016b). In addition, another study reported that
Lactobacillus was a dominant genus in urine samples from
premenopausal women (Karstens et al., 2016). Although age
and menopausal status play a role in the relative abundance of
Lactobacillus, hypertension may also be a risk factor for reduced
levels of Lactobacillus. The DM+HT cohort did not include a
significantly greater number of postmenopausal women than the
DM+HLP cohort, but the relative abundance of Lactobacillus
was still significantly lower in the DM+HT compared to in the
DM+HLP cohort. Furthermore, it has been reported that oral
administration of recombinant Lactobacillus can significantly
decrease systolic BP (Yang et al., 2015). Future studies should
explore whether a deficiency in Lactobacillus is responsible
for the co-occurrence of hypertension in those with diabetes
or whether the co-occurrence of hypertension causes the low
relative abundance of Lactobacillus in urine. Notably, among
the four cohorts, the DM+HT subjects had the highest rates
of asymptomatic bacteriuria and nitrite-positive samples and
lowest relative abundance of Lactobacillus. Hypertension is a
risk factor for UTIs in diabetic patients (Al-Rubeaan et al.,
2013) and Lactobacillus can reduce UTIs (Marelli et al.,
2004).
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Interestingly, not only was the relative abundance of
Oscillospira dramatically higher in the DM+HLP cohort
compared to in the DM cohort, but it was also capable of
being used as a diagnostic factor for differentiating those in
the DM+HLP cohort from those in the DM. If this finding
is confirmed by a study with a larger sample size, the relative
abundance of Oscillospira could be used as a measure for patients
with diabetes to self-monitor hyperlipidemia.
The relative abundance of Faecalibacterium was higher in the
DM+HLP cohort than in the DM cohort. It has been reported
that patients with urgent urinary incontinence also have a higher
proportion of Faecalibacterium than healthy controls (Pearce
et al., 2014), and hyperlipidemia has been shown to increase
urinary frequency and decrease the density of blood vessels and
nerves in the bladder (Huang et al., 2010). This suggests that
reducing the relative abundance of Faecalibacterium in urinemay
be useful for controlling hyperlipidemia in patients with urgent
urinary incontinence.
There was a significantly higher relative abundance of
Prevotella in the DM+HT+HLP cohort compared to in the DM
cohort. In addition, among the four cohorts, the DM cohort
had the lowest relative abundance of Prevotella. A previous
study reported that the relative abundance of Prevotella was
higher in patients with urgency urinary incontinence compared
to healthy controls (Pearce et al., 2014), and compared to
healthy controls, those with urgency urinary incontinence had
a significantly higher mean body mass index (which is a good
predictor of hyperlipidemia) (Rao et al., 2016), and a greater
degree of hypertension (Pearce et al., 2014). Therefore, the high
relative abundance of Prevotella may be a causal factor in the
development of hypertension and hyperlipidemia.
At the genus level, we found that several bacteria correlated
with FBG, BP, and BL. Atopobium was positively correlated
with FBG in the DM cohort, which conflicts with the findings
of a recent intestinal study in which the relative abundance
of Atopobium was lower in those with diabetes compared
to in healthy controls (Sato et al., 2014). Allobaculum was
negatively correlated with diastolic BP in the DM+HT cohort.
An intestinal microbiota study revealed that mice eating a
high fat diet (which is associated with high BP) had a lower
relative abundance of Allobaculum than controls (Ravussin
et al., 2011). Therefore, reducing the relative abundance of
Allobaculum in urine may be useful for controlling BP if the
association between urinaryAllobaculum and BP is similar to that
between intestinal Allobaculum and BP. The relative abundance
of Rikenella was positively correlated with triglycerides in the
DM+HLP cohort. This finding is similar to the findings of a
previous study that detected Rikenella in the ceca of diabetic
mice with dyslipidemia (Harris et al., 2012). In addition, a
recent study of intestinal microbiota revealed that the relative
abundance of Odoribacter is negatively correlated with systolic
BP (Gomez-Arango et al., 2016), which is somewhat similar
to the findings in the present study, as the relative abundance
of Odoribacter in the DM+HT+HLP cohort was negatively
associated with diastolic BP. Moreover, Chen et al. reported a
positive correlation between Dorea and LDL-C in a rat model
of hyperlipidemia (Chen D. et al., 2014), and Dorea was also
positively associated with LDL-C in the DM+HT+HLP cohort
in the present study.
The relative abundance of L. iners, which has been reported
to be the most abundant sequence in the urine of patients
with sexually transmitted infections (Nelson et al., 2010), was
dramatically higher in the DM+HT cohort than in the DM
cohort. Several studies have detected L. iners in people with
infections, indicating that it does not protect against infections
(Saunders et al., 2007; Tamrakar et al., 2007). This corresponds
with the fact that higher levels of L. iners might be correlated
with asymptomatic bacteriuria and nitrite-positive samples in
the DM+HT cohort. In addition, E. lenta, which has been
shown to be correlated with the occurrence of bacteremia
(Gardiner et al., 2015), was not detected in the DM cohort
but was detected in the DM+HT cohort. This suggests that
the elevated inflammatory response in those with diabetes
plus hypertension may be related to the presence of E. lenta.
The relative abundance of A. rhizosphaerae was lower in the
DM+HT+HLP cohort compared to in the DM cohort, and
the relative abundance of this bacteria was also lower in the
DM+HT+HLP cohort compared to in the DM+HLP cohort,
which suggests that hypertension plays a role in inhibiting this
species.
The main limitation of the study was that the sizes of
the four cohorts were not equal, and some were particularly
small, which may bias the results as it can make it more
difficult to detect differences between the cohorts. Furthermore,
in the DM+HT, DM+HLP, and DM+HT+HLP cohorts, the
participants could not recall sequence of the occurrences of
their conditions, so we could not use information on the onset
of these conditions to determine the influences on the urinary
microbiota profiles. In addition, although nutrient intakes were
not strongly associated with urinary microbiota and no previous
study reported that urinay microbiota were affected by food
and supplements intake (Nelson et al., 2010; Dong et al., 2011;
Siddiqui et al., 2011, 2012, 2014; Fouts et al., 2012; Wolfe
et al., 2012; Fricke et al., 2014; Nienhouse et al., 2014; Pearce
et al., 2014, 2015; Price et al., 2016; Shoskes et al., 2016;
Thomas-White et al., 2016b), it might skew the results. We
would enroll participants who has the same amounts of food
and supplements intake in our future study to rule out the
effects of food, supplements and medicine intake on urinary
microbiota.
CONCLUSIONS
This is the first study to investigate the association between
urinary microbiota profiles and comorbid hypertension and
hyperlipidemia in those with T2DM. It demonstrated that the
co-occurrence of hypertension and hyperlipidemia in those
with T2DM affects the relative abundance of various bacteria
in urine. UTIs may be affected by the relative abundances of
Proteobacteria, Lactobacillus, and L. iners. FBG, BP, and BL were
correlated with the relative abundances of several bacteria. The
urinary system is a vital excretory system for metabolic waste and
it plays a crucial role in regulatingmetabolic diseases. The urinary
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microenvironment (which is produced by the composition of
urine) has a large impact on the reproduction of the microflora.
Therefore, it is important to further investigate the mechanisms
behind the association of urinary microbiota with hypertension,
hyperlipidemia, and urinary tract infections, as this may be
useful for developing microbiota-based treatment to control
hypertension, hyperlipidemia, and bladder infections in those
with diabetes.
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